ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 653 filers reported holding ISHARES TR in Q2 2019. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,330 | -3.7% | 68 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,648 | -1.7% | 68 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,798 | -1.6% | 68 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $8,938 | -44.1% | 68 | -51.4% | 0.00% | -66.7% |
| Q3 2022 | $16,000 | 0.0% | 140 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $16,000 | -11.1% | 140 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $18,000 | -14.3% | 140 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $21,000 | +90.9% | 140 | +100.0% | 0.00% | +50.0% |
| Q4 2020 | $11,000 | -42.1% | 70 | -50.4% | 0.00% | -33.3% |
| Q3 2020 | $19,000 | -13.6% | 141 | -22.5% | 0.00% | -50.0% |
| Q4 2019 | $22,000 | +22.2% | 182 | 0.0% | 0.01% | +20.0% |
| Q3 2019 | $18,000 | -10.0% | 182 | -3.2% | 0.01% | -28.6% |
| Q2 2019 | $20,000 | +17.6% | 188 | +3.9% | 0.01% | 0.0% |
| Q4 2018 | $17,000 | -22.7% | 181 | 0.0% | 0.01% | -22.2% |
| Q3 2018 | $22,000 | – | 181 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |